Cytodyn Inc (CYDY)

[justdafactss]

Seems strange AGC is mentioned and not Samsung

Forecast to be delivered to Samsung by March 31, 2020, but 3 days after that 3/31/20 due date, on April 3, 2020, KIRO News Seattle reports AGC Biologics is Cytodyn's manufacturer of leronlimab (PRO 140)
.

Did Cytodyn default on their agreement with Samsung?

Page 23 of the 1/9/2020 10-Q SEC filing:

In April 2019 the Company delivered to Samsung a purchase order for $33 million worth of process validation and technology transfer services related to the manufacture of leronlimab, with payments by the Company scheduled to be made throughout calendar 2020. Under the Samsung Agreement, the purchase order is binding and the Company is obligated to pay the full amount of the purchase order. Under the terms of the Samsung Agreement, the Company is obligated to make specified minimum purchases of leronlimab from Samsung pursuant to forecasted requirements which the Company will provide to Samsung. The first forecast will be delivered to Samsung by March 31, 2020. Thereafter, the Company must provide Samsung with a rolling quarterly forecast setting forth the total quantity of commercial grade leronlimab that the Company expects to require in the following years. The Company estimates that initial ramp-up costs to manufacture commercial grade leronlimab at scale could total approximately $60 million, with approximately $30 million payable over the course of calendar 2020, and approximately $30 million payable in the first quarter of 2021. Thereafter, the Company will pay Samsung per 15,000L batch according to the pricing terms specified in the Samsung Agreement
https://www.sec.gov/Archives/edgar/data/1175680/000119312520004683/d855842d10q.htm